Literature DB >> 12843257

The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo.

Ju Young Kim1, Qin Sun, Michael Oglesbee, Sung Ok Yoon.   

Abstract

The knock-out analyses of neuregulin and its receptors have indicated that they play essential roles in Schwann cell development. However, the role they play in oligodendrocyte development in vivo has remained unclear, because such knock-out animals die before CNS myelination begins. We examined the role of neuregulin signaling in the CNS by generating transgenic mice that express a dominant-negative mutant of the ErbB2 receptor among oligodendrocytes, using an MBP promoter. The transgenic mice exhibited widespread hypomyelination, resulting from a reduction in oligodendrocyte differentiation. The number of progenitors was conversely increased in the transgenic mice. We report that a reduction in oligodendrocyte differentiation is attributed in part to apoptosis of oligodendrocyte progenitors as they exit the cell cycle. A significant reduction in the number of p27+ oligodendrocyte precursors in the transgenic mice supports this conclusion. Taken together, these data suggest that for oligodendrocyte progenitors, ErbB2 signaling plays a role in governing a properly timed exit from the cell cycle during development into myelinating oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843257      PMCID: PMC6741253     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury.

Authors:  A W Harrington; B Leiner; C Blechschmitt; J C Arevalo; R Lee; K Mörl; M Meyer; B L Hempstead; S O Yoon; K M Giehl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

Review 2.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

3.  Opposite regulation of oligodendrocyte apoptosis by JNK3 and Pin1 after spinal cord injury.

Authors:  Qi Ming Li; Chhavy Tep; Tae Y Yune; Xiao Zhen Zhou; Takafumi Uchida; Kun Ping Lu; Sung Ok Yoon
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 4.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

Review 5.  Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage.

Authors:  Olaf Dammann; Wolfgang Bueter; Alan Leviton; Pierre Gressens; Christiane E L Dammann
Journal:  Neonatology       Date:  2007-11-09       Impact factor: 4.035

6.  Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls.

Authors:  Fei Wang; Tianzi Jiang; Zhiguo Sun; Siew-Leng Teng; Xingguang Luo; Zhongjun Zhu; Yufeng Zang; Handi Zhang; Weihua Yue; Mei Qu; Tianlan Lu; Nan Hong; Haiyan Huang; Hilary P Blumberg; Dai Zhang
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

Review 7.  Oligodendrocytes: biology and pathology.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2009-10-22       Impact factor: 17.088

8.  Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system.

Authors:  Bastian G Brinkmann; Amit Agarwal; Michael W Sereda; Alistair N Garratt; Thomas Müller; Hagen Wende; Ruth M Stassart; Schanila Nawaz; Christian Humml; Viktorija Velanac; Konstantin Radyushkin; Sandra Goebbels; Tobias M Fischer; Robin J Franklin; Cary Lai; Hannelore Ehrenreich; Carmen Birchmeier; Markus H Schwab; Klaus Armin Nave
Journal:  Neuron       Date:  2008-08-28       Impact factor: 17.173

9.  Erbin regulates NRG1 signaling and myelination.

Authors:  Yanmei Tao; Penggao Dai; Yu Liu; Sylvie Marchetto; Wen-Cheng Xiong; Jean-Paul Borg; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-20       Impact factor: 11.205

10.  Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours.

Authors:  T Gelardi; V Damiano; R Rosa; R Bianco; R Cozzolino; G Tortora; P Laccetti; G D'Alessio; C De Lorenzo
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.